Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B

被引：0
|
作者：
Teerha Piratvisuth
George Lau
You-Chen Chao
Rui Jin
Anuchit Chutaputti
Q.-B. Zhang
Tawesak Tanwandee
Peter Button
Matei Popescu
机构：
[1] Prince of Songkla University,Department of Internal Medicine, NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital
[2] Queen Mary Hospital,Department of Medicine
[3] Tri-Service General Hospital,Division of Gastroenterology and Hepatology
[4] Beijing You-An Hospital,Digestive Department
[5] Pramongkutklao Hospital,Section of Digestive and Liver Disease
[6] Huashan Hospital,Infectious Diseases Department
[7] Sirirai Hospital,Department of Medicine
[8] Roche Product Pty Limited,Pharmaceuticals Division
[9] Roche,undefined
来源：
Hepatology International | 2008年 / 2卷
关键词：
HBeAg seroconversion; Combined response; Peginterferon alfa-2a; CHB; Asian patients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：102 / 110
页数：8
相关论文
共 50 条
  • [1] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [2] Response to peginterferon alfa-2a (40KD) (PEGASYS) treatment in patients with bridging fibrosis in HBeAg-positive and HBeAg-negative chronic hepatitis B
    Cooksley, Graham
    Lau, George
    Marcellin, Patrick
    Piratvisuth, Teerha
    Lai, Ming-Yang
    Bonino, Ferruccio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A32 - A32
  • [3] Predicting response to peginterferon alfa-2a (40 KD) (PEGASYS®) in Asian patients with HBeAg-positive chronic hepatitis B
    Cooksley, Graham
    Chow, Wan Cheng
    Piratvisuth, Teerha
    Lau, George K. K.
    Mccloud, Philip
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A108 - A108
  • [4] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    Lau, GKK
    Piratvisuth, T
    Luo, KX
    Marcellin, P
    Thongsawat, S
    Cooksley, G
    Gane, E
    Fried, MW
    Chow, WC
    Paik, SW
    Chang, WY
    Berg, T
    Flisiak, R
    McCloud, P
    Pluck, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2682 - 2695
  • [5] Predictors of histologic improvement and relationship between sustained response and histology in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS®)
    Lau, GK
    Cooksley, G
    Marcellin, P
    Piratvisuth, T
    Hadziyannis, S
    Farci, P
    Fried, MW
    Bonino, F
    Jin, R
    Button, P
    Popescu, M
    HEPATOLOGY, 2005, 42 (04) : 587A - 587A
  • [6] ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS®), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone
    Piratvisuth, T
    Marcellin, P
    Lau, G
    Bonino, F
    Farci, P
    Hadziyannis, S
    Jin, R
    Lu, ZM
    Germanidis, G
    Yurdaydin, C
    Diago, M
    Gurel, S
    Lai, MY
    Button, P
    Why, RD
    Pluck, N
    HEPATOLOGY, 2004, 40 (04) : 656A - 657A
  • [7] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
  • [8] Asian patients with HBeAg-negative chronic hepatitis B respond well to peginterferon alfa-2a (40 KD) (PEGASYS®) treatment
    Jia, Ji-Dong
    Piratvisuth, Teerha
    Lau, George K. K.
    Luo, Kang-Xian
    Jin, Rui
    Lu, Zhi-Meng
    Marcellin, Patrick
    Popescu, Matei
    Button, Peter
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A88 - A88
  • [9] Efficacy and Safety of Peginterferon alfa-2a (40KD) in HBeAg-positive Chronic Hepatitis B Patients
    Caruntu, Florin Alexandru
    Streinu-Cercel, Adrian
    Gheorghe, Liliana Simona
    Grigorescu, Mircea
    Sporea, Ioan
    Stanciu, Carol
    Andronescu, Dan
    Voinea, Florea
    Diculescu, Mircea
    Oproiu, Alexandru
    Voiosu, Rodu
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2009, 18 (04) : 425 - 431
  • [10] On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
    Goulis, Ioannis
    Karatapanis, Stylianos
    Akriviadis, Evangelos
    Deutsch, Melanie
    Dalekos, George N.
    Raptopoulou-Gigi, Maria
    Mimidis, Konstantinos
    Germanidis, George
    Drakoulis, Christos
    Triantos, Christos
    Zintzaras, Elias
    Bakalos, Georgios
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2015, 35 (05) : 1540 - 1548
12345